Approvals on the Rise, Though Translational Work Still Key
By Nuala Moran
Tuesday, February 19, 2013
BOSTON The rise in the number of new drug approvals granted by the FDA in the past three years looks encouraging hinting as it does that the industry is putting the productivity woes of the previous decade behind it.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.